Report for Sawada N

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (3)

Title : A practical use of ligand efficiency indices out of the fragment-based approach: ligand efficiency-guided lead identification of soluble epoxide hydrolase inhibitors - Tanaka_2011_J.Med.Chem_54_851
Author(s) : Tanaka D , Tsuda Y , Shiyama T , Nishimura T , Chiyo N , Tominaga Y , Sawada N , Mimoto T , Kusunose N
Ref : Journal of Medicinal Chemistry , 54 :851 , 2011
Abstract : Tanaka_2011_J.Med.Chem_54_851
ESTHER : Tanaka_2011_J.Med.Chem_54_851
PubMedSearch : Tanaka_2011_J.Med.Chem_54_851
PubMedID: 21192659
Gene_locus related to this paper: human-EPHX2

Title : The forefront for novel therapeutic agents based on the pathophysiology of lower urinary tract dysfunction: pathophysiology of voiding dysfunction and pharmacological therapy - Takeda_2010_J.Pharmacol.Sci_112_121
Author(s) : Takeda M , Araki I , Mochizuki T , Nakagomi H , Kobayashi H , Sawada N , Zakohji H
Ref : J Pharmacol Sci , 112 :121 , 2010
Abstract : Takeda_2010_J.Pharmacol.Sci_112_121
ESTHER : Takeda_2010_J.Pharmacol.Sci_112_121
PubMedSearch : Takeda_2010_J.Pharmacol.Sci_112_121
PubMedID: 20134111

Title : Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue - Miwa_1998_Eur.J.Cancer_34_1274
Author(s) : Miwa M , Ura M , Nishida M , Sawada N , Ishikawa T , Mori K , Shimma N , Umeda I , Ishitsuka H
Ref : Eur J Cancer , 34 :1274 , 1998
Abstract : Miwa_1998_Eur.J.Cancer_34_1274
ESTHER : Miwa_1998_Eur.J.Cancer_34_1274
PubMedSearch : Miwa_1998_Eur.J.Cancer_34_1274
PubMedID: 9849491